Biogen Idec Inc. XBRL Taxonomy Presentation Networks

-Network: (00 - Document - Document and Company Information)
-Document and Entity Information [Abstract] {ID1}
Entity Registrant Name {ID2}
Entity Central Index Key {ID3}
Document Type {ID4}
Document Period End Date {ID5}
Amendment Flag {ID6}
Amendment Description {ID7}
Current Fiscal Year End Date {ID8}
Entity Well-known Seasoned Issuer {ID9}
Entity Voluntary Filers {ID10}
Entity Current Reporting Status {ID11}
Entity Filer Category {ID12}
Entity Public Float {ID13}
Entity Common Stock, Shares Outstanding {ID14}
-Network: (01 - Statement - Consolidated Statements of Income)
-Statements of Income [Abstract] {ID15}
-Statement [Table] {ID16}
-Statement [Line Items] {ID17}
-Revenues: {ID18}
Product {ID19}
Unconsolidated joint business {ID20}
Other revenues {ID21}
Total revenues {ID22}
-Costs and expenses: {ID23}
Cost of sales, excluding amortization of acquired intangible assets {ID24}
Research and development {ID25}
Selling, general and administrative {ID26}
Collaboration profit sharing {ID27}
Amortization of acquired intangible assets {ID28}
Acquired in-process research and development {ID29}
Total costs and expenses {ID30}
Income from operations {ID31}
Other income (expense), net {ID32}
Income before income tax expense {ID33}
Income tax expense {ID34}
Net income {ID35}
Net income attributable to noncontrolling interest, net of tax {ID36}
Net income attributable to Biogen Idec Inc. {ID37}
Basic earnings per share attributable to Biogen Idec Inc. {ID38}
Diluted earnings per share attributable to Biogen Idec Inc. {ID39}
-Weighted-average shares used in calculating: {ID40}
Basic earnings per share attributable to Biogen Idec Inc. {ID41}
Diluted earnings per share attributable to Biogen Idec Inc. {ID42}
-Network: (02 - Statement - Consolidated Balance Sheets)
-Balance Sheets [Abstract] {ID43}
-Statement [Table] {ID44}
-Statement [Line Items] {ID45}
-Current assets: {ID47}
Cash and cash equivalents {ID48}
Marketable securities {ID49}
Collateral received for loaned securities {ID50}
Accounts receivable, net {ID51}
Due from unconsolidated joint business {ID52}
Loaned securities {ID53}
Inventory {ID54}
Other current assets {ID55}
Total current assets {ID56}
Marketable securities {ID57}
Property, plant and equipment, net {ID58}
Intangible assets, net {ID59}
Goodwill {ID60}
Investments and other assets {ID61}
Total assets {ID62}
-Current liabilities: {ID64}
Collateral payable on loaned securities {ID65}
Accounts payable {ID66}
Taxes payable {ID67}
Accrued expenses and other {ID68}
Current portion of notes payable and line of credit {ID69}
Total current liabilities {ID70}
Notes payable and line of credit {ID71}
Long-term deferred tax liability {ID72}
Other long-term liabilities {ID73}
Total liabilities {ID74}
Commitments and contingencies {ID75}
-Equity: {ID76}
Preferred stock, par value $0.001 per share {ID77}
Common stock, par value $0.0005 per share {ID78}
Additional paid-in capital {ID79}
Accumulated other comprehensive income (loss) {ID80}
Retained earnings {ID81}
Treasury stock, at cost {ID82}
Total Biogen Idec Inc. shareholders' equity {ID83}
Noncontrolling interest {ID84}
Total equity {ID85}
Total liabilities and equity {ID86}
-Network: (021 - Statement - Consolidated Balance Sheets (Parenthetical))
-Balance Sheets (Parenthetical) [Abstract] {ID87}
-Statement [Table] {ID88}
-Statement [Line Items] {ID89}
Preferred stock, par value {ID90}
Common stock, par value {ID91}
-Network: (03 - Statement - Consolidated Statements of Cash Flows)
-Statements of Cash Flows [Abstract] {ID92}
-Statement [Table] {ID93}
-Statement [Line Items] {ID94}
-Cash flows from operating activities: {ID95}
Net income {ID96}
-Adjustments to reconcile net income to net cash flows from operating activities: {ID97}
Depreciation and amortization of property, plant and equipment and intangible assets {ID98}
Acquired in-process research and development {ID99}
Share-based compensation {ID100}
Non-cash interest (income) expense and foreign exchange remeasurement loss (gain), net {ID101}
Deferred income taxes {ID102}
Realized gain on sale of marketable securities and strategic investments {ID103}
Write-down of inventory to net realizable value {ID104}
Impairment of marketable securities, investments and other assets {ID105}
Excess tax benefit from stock options {ID106}
-Changes in operating assets and liabilities, net: {ID107}
Accounts receivable {ID108}
Due from unconsolidated joint business {ID109}
Inventory {ID110}
Other assets {ID111}
Accrued expenses and other current liabilities {ID112}
Other liabilities and taxes payable {ID113}
Net cash flows provided by operating activities {ID114}
-Cash flows from investing activities: {ID115}
Purchases of marketable securities {ID116}
Proceeds from sales and maturities of marketable securities {ID117}
Collateral received under securities lending {ID118}
Acquisitions, net of cash acquired {ID119}
Purchases of property, plant and equipment {ID120}
Purchases of other investments {ID121}
Proceeds from the sale of a strategic equity investment {ID122}
Net cash flows (used in) provided by investing activities {ID123}
-Cash flows from financing activities: {ID124}
Purchase of treasury stock {ID125}
Proceeds from issuance of stock for share-based compensation arrangements {ID126}
Change in cash overdraft {ID127}
Excess tax benefit from stock options {ID128}
Proceeds from borrowings {ID129}
Repayment of borrowings {ID130}
Obligation under securities lending {ID131}
Net cash flows used in financing activities {ID132}
Net increase (decrease) in cash and cash equivalents {ID133}
Effect of exchange rate changes on cash and cash equivalents {ID134}
Cash and cash equivalents, beginning of the period {ID135}
Cash and cash equivalents, end of the period {ID136}
-Network: (0601 - Disclosure - Business Overview)
-Business Overview [Abstract] {ID137}
Business Overview {ID138}
-Network: (0602 - Disclosure - Inventory)
-Inventory [Abstract] {ID139}
Inventory {ID140}
-Network: (0603 - Disclosure - Revenue Recognition)
-Revenue Recognition [Abstract] {ID141}
Revenue Recognition {ID142}
-Network: (0604 - Disclosure - Intangible Assets and Goodwill)
-Intangible Assets and Goodwill [Abstract] {ID143}
Intangible Assets and Goodwill {ID144}
-Network: (0605 - Disclosure - Fair Value Measurements)
-Fair Value Measurements [Abstract] {ID145}
Fair Value Measurements {ID146}
-Network: (0606 - Disclosure - Financial Instruments)
-Financial Instruments [Abstract] {ID147}
Financial Instruments {ID148}
-Network: (0607 - Disclosure - Property Plant and Equipment)
-Property Plant and Equipment Disclosure [Abstract] {ID149}
Property, Plant and Equipment {ID150}
-Network: (0608 - Disclosure - Equity)
-Equity Note Disclosure [Abstract] {ID151}
Equity {ID152}
-Network: (0609 - Disclosure - Earnings per Share)
-Earnings per Share Disclosure [Abstract] {ID153}
Earnings per Share {ID154}
-Network: (0610 - Disclosure - Share Based Payments)
-Share-Based Payments [Abstract] {ID155}
Share-Based Payments {ID156}
-Network: (0611 - Disclosure - Income Taxes)
-Income Taxes [Abstract] {ID157}
Income Taxes {ID158}
-Network: (0612 - Disclosure - Other Income (Expense), Net)
-Other Income (Expense), Net [Abstract] {ID159}
Other Income (Expense), Net {ID160}
-Network: (0613 - Disclosure - Collaborations)
-Collaborations [Abstract] {ID161}
Collaborations {ID162}
-Network: (0614 - Disclosure - Litigation)
-Litigation [Abstract] {ID163}
Litigation {ID164}
-Network: (0615 - Disclosure - Segment Information)
-Segment Information [Abstract] {ID165}
Segment Information {ID166}
-Network: (0616 - Disclosure - New Accounting Pronouncements)
-New Accounting Pronouncements [Abstract] {ID167}
New Accounting Pronouncements {ID168}